Primer on Diabetes Management

Symposium on Diabetes and Cancer 2017: Novel Links and Treatments

S. Inzucchi

Health of Vegetarians and Vegans: Findings From EPIC-Oxford and Othe…

Physicians Committee for Responsible Medicine

T. J. Key

Role of PCSK9 Inhibitors in Diabetes

Stephen Kopecky

New Insights into Triglyceride Therapy and the Role of Omega-3 Fatty…

National Lipid Association

R. Mason

Weightloss in Menopause

Susan Brian

The GOOD and the BAD Side of GLP-1s and What to Do If You Get Caught…

Endocrinology 2024 Year in Review

Updated Lipid Guidelines and Therapy

Complex Coronary Cases

I. Fergus

Review of Coronary Artery Calcium Testing for Primary Care

Dr. Catherine P. Benziger

C. Benziger

Role of Coronary Calcification and Risk Stratification

The Texas Heart Institute

E. Hernandez

Hypertension 2025: New Guidelines and Resistant Hypertension

University of Louisville

K. Ferdinand

Recent Cholesterol Guidelines and Integration into Clinical Practice

Vasculearn Network

J. Plutzky, L. Braun, J. Ross

Diabetes Treatment Guidelines Finally Have Entered the 21st Century …

ASPC 2019 Congress on CVD Prevention

R. DeFronzo

SURPASS 2: Tirzepatide Versus Once-Weekly Semaglutide

Juan Frias

GLP-1/GIP Update: Stay Tuned... The Best is Yet to Come!!

Robert Busch

Labs to Check on Semaglutide or Tirzepatide

Susan Brian

Lipids Update: Current Guidelines for Lipid Management

Scripps Health

S. R. Mehta

ACC 2023: Management of Statin Side Effects and How to Keep Them on …

ACC 2023 Conference Coverage

J. Saseen

Cardiology’s Biggest Controversy: The Lumen or the Wall - the Curiou…

Cedars Sinai

J. Forrester

SGLT2 Inhibitors, GLP1 Receptor Agonists, and Renal Outcomes

Cardiometabolic Health Congress (CMHC)

L. Sloan

Cholesterol Treatment Decisions: Recent Updates to Guidelines and St…

Gary Martin